Cognitive enhancement therapy for a model of Down syndrome.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 20368181.
- Also identified by DOI 10.1126/scitranslmed.3000449.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Down syndrome is a complex condition that results from having a third copy of human chromosome 21. People with the syndrome experience problems with learning and memory that affect many aspects of their lives. In this issue of Science Translational Medicine, Salehi et al. report on successful drug treatment of learning deficits in an animal model of Down syndrome. This study highlights the function of the norepinephrine-ergic system in Down syndrome and suggests possible treatment options for people with Down syndrome.
Medical subject headings
- Cognition
- Down Syndrome
- Models, Theoretical